Literature DB >> 18404434

Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices.

Elisabetta Coppi1, Anna Maria Pugliese, Holger Stephan, Christa E Müller, Felicita Pedata.   

Abstract

The role of ATP and its stable analogue ATPgammaS [adenosine-5'-o-(3-thio)triphosphate] was studied in rat hippocampal neurotransmission under normoxic conditions and during oxygen and glucose deprivation (OGD). Field excitatory postsynaptic potentials (fEPSPs) from the dendritic layer or population spikes (PSs) from the soma were extracellularly recorded in the CA1 area of the rat hippocampus. Exogenous application of ATP or ATPgammaS reduced fEPSP and PS amplitudes. In both cases the inhibitory effect was blocked by the selective A(1) adenosine receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine) and was potentiated by different ecto-ATPase inhibitors: ARL 67156 (6-N,N-diethyl-D: -beta,gamma-dibromomethylene), BGO 136 (1-hydroxynaphthalene-3,6-disulfonate) and PV4 [hexapotassium dihydrogen monotitanoundecatungstocobaltate(II) tridecahydrate, K(6)H(2)[TiW(11)CoO(40)].13H(2)O]. ATPgammaS-mediated inhibition was reduced by the P2 antagonist suramin [8-(3-benzamido-4-methylbenzamido)naphthalene-1,3,5-trisulfonate] at the somatic level and by other P2 blockers, PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonate) and MRS 2179 (2'-deoxy-N (6)-methyladenosine 3',5'-bisphosphate), at the dendritic level. After removal of both P2 agonists, a persistent increase in evoked synaptic responses was recorded both at the dendritic and somatic levels. This effect was prevented in the presence of different P2 antagonists. A 7-min OGD induced tissue anoxic depolarization and was invariably followed by irreversible loss of fEPSP. PPADS, suramin, MRS2179 or BBG (brilliant blue G) significantly prevented the irreversible failure of neurotransmission induced by 7-min OGD. Furthermore, in the presence of these P2 antagonists, the development of anoxic depolarization was blocked or significantly delayed. Our results indicate that P2 receptors modulate CA1 synaptic transmission under normoxic conditions by eliciting both inhibitory and excitatory effects. In the same brain region, P2 receptor stimulation plays a deleterious role during a severe OGD insult.

Entities:  

Year:  2007        PMID: 18404434      PMCID: PMC2096646          DOI: 10.1007/s11302-006-9049-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  86 in total

Review 1.  Molecular physiology of P2X receptors and ATP signalling at synapses.

Authors:  B S Khakh
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

2.  Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists.

Authors:  F Cavaliere; N D'Ambrosi; M T Ciotti; G Mancino; G Sancesario; G Bernardi; C Volonté
Journal:  Neurochem Int       Date:  2001-03       Impact factor: 3.921

Review 3.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

4.  Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons.

Authors:  S Hugel; R Schlichter
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

5.  ATP contributes to the generation of network-driven giant depolarizing potentials in the neonatal rat hippocampus.

Authors:  Victoria F Safiulina; Alexander M Kasyanov; Elena Sokolova; Enrico Cherubini; Rashid Giniatullin
Journal:  J Physiol       Date:  2005-04-21       Impact factor: 5.182

6.  Excitatory and inhibitory effects of adenosine on the neurotransmission in the hippocampal slices of guinea pig.

Authors:  S Nishimura; M Mohri; Y Okada; M Mori
Journal:  Brain Res       Date:  1990-08-13       Impact factor: 3.252

7.  Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.

Authors:  S Latini; F Bordoni; F Pedata; R Corradetti
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.

Authors:  E Camaioni; J L Boyer; A Mohanram; T K Harden; K A Jacobson
Journal:  J Med Chem       Date:  1998-01-15       Impact factor: 7.446

9.  Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex.

Authors:  Kerstin Wirkner; Laszlo Köles; Susanne Thümmler; Julia Luthardt; Wolfgang Poelchen; Heike Franke; Susanna Fürst; Peter Illes
Journal:  Neuropharmacology       Date:  2002-03       Impact factor: 5.250

10.  Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.

Authors:  Kazuaki Yoshioka; Osamu Saitoh; Hiroyasu Nakata
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

View more
  11 in total

1.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

2.  Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia.

Authors:  Qiang Yu; Zhili Guo; Xiaofeng Liu; Qing Ouyang; Cheng He; Geoffrey Burnstock; Hongbin Yuan; Zhenghua Xiang
Journal:  Purinergic Signal       Date:  2013-07-23       Impact factor: 3.765

3.  Modulation of ATP-induced LTP by cannabinoid receptors in rat hippocampus.

Authors:  Olexandr Ievglevskyi; Oleg Palygin; Elena Kondratskaya; Sergei Grebenyuk; Oleg Krishtal
Journal:  Purinergic Signal       Date:  2012-03-28       Impact factor: 3.765

4.  Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia.

Authors:  Mirko Muzzi; Francesco Blasi; Alessio Masi; Elisabetta Coppi; Chiara Traini; Roberta Felici; Maria Pittelli; Leonardo Cavone; Anna Maria Pugliese; Flavio Moroni; Alberto Chiarugi
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-24       Impact factor: 6.200

5.  Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).

Authors:  Younis Baqi; Stefanie Weyler; Jamshed Iqbal; Herbert Zimmermann; Christa E Müller
Journal:  Purinergic Signal       Date:  2008-06-05       Impact factor: 3.765

6.  Caffeine has a dual influence on NMDA receptor-mediated glutamatergic transmission at the hippocampus.

Authors:  Robertta S Martins; Diogo M Rombo; Joana Gonçalves-Ribeiro; Carlos Meneses; Vladimir P P Borges-Martins; Joaquim A Ribeiro; Sandra H Vaz; Regina C C Kubrusly; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2020-10-06       Impact factor: 3.765

7.  Inhibition of hippocampal synaptic activity by ATP, hypoxia or oxygen-glucose deprivation does not require CD73.

Authors:  Dali Zhang; Wei Xiong; Stephanie Chu; Chao Sun; Benedict C Albensi; Fiona E Parkinson
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

8.  The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Authors:  F Pedata; A Melani; A M Pugliese; E Coppi; S Cipriani; C Traini
Journal:  Purinergic Signal       Date:  2007-10-11       Impact factor: 3.765

9.  The selective antagonism of P2X7 and P2Y1 receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrus.

Authors:  Giovanna Maraula; Daniele Lana; Elisabetta Coppi; Francesca Gentile; Tommaso Mello; Alessia Melani; Andrea Galli; Maria Grazia Giovannini; Felicita Pedata; Anna Maria Pugliese
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

10.  The Selective Antagonism of Adenosine A2B Receptors Reduces the Synaptic Failure and Neuronal Death Induced by Oxygen and Glucose Deprivation in Rat CA1 Hippocampus in Vitro.

Authors:  Irene Fusco; Filippo Ugolini; Daniele Lana; Elisabetta Coppi; Ilaria Dettori; Lisa Gaviano; Daniele Nosi; Federica Cherchi; Felicita Pedata; Maria G Giovannini; Anna M Pugliese
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.